Search: Fenom Pro®

Displaying Results 4 of 4

Vyaire Medical Enters Exclusive, Five-Year Agreement to Distribute Spirosure's Fenom Pro® Asthma Monitor in Multiple Countries

Spirosure’s Fenom Pro is one of two FDA-cleared devices that measures FeNO, the most established biomarker for diagnosing and managing asthma. FeNO—Fractional exhaled Nitric…

Fenom Pro®

The Fenom Pro® point-of-care breath analyzer measures Fractional Exhaled Nitric Oxide (FeNO) molecules. FeNO is an objective biomarker of allergic airway…

Fenom Pro®

The Fenom Pro® point-of-care breath analyzer measures Fractional Exhaled Nitric Oxide (FeNO) molecules. FeNO is an objective biomarker of allergic airway inflammation, an indicator of asthma and other pulmonary conditions. FeNO testing is recommended in the ATS guidelines.

Vyaire Medical Enters Exclusive, Five-Year Agreement to Distribute Spirosure's Fenom Pro® Asthma Monitor in Multiple Countries

CHICAGO and PLEASANTON, Calif. – January 8, 2020 ― Vyaire Medical, Inc. and Spirosure, Inc. have entered a five-year agreement for Vyaire to exclusively…